Christian Faul

Novel concepts in understanding and management of glomerular proteinuria.

Hypereosinophilic syndrome associated with heterozygous factor V gene mutation: an unusual combination resulting in an acute coronary syndrome and recurrent cerebral stroke-a case report.

Induction of B7-1 in podocytes is associated with nephrotic syndrome.

Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner.

Promotion of importin alpha-mediated nuclear import by the phosphorylation-dependent binding of cargo protein to 14-3-3.

TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.

Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling.

Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes.

Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.

Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton.

Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes.

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease.

Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice.

COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness.

Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival.

Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival.

FGF23 induces left ventricular hypertrophy.

Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin α in RhoA stabilization.

Acute pulmonary embolism in patients with obstructive sleep apnoea: does it affect the severity of sleep-disordered breathing?

TRPC6 in podocytes: questions and commentary on the article by Jiang et al., 'Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca21 and RhoA activation'.

Differences of cardiac output measurements by open-circuit acetylene uptake in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a cohort study.

Fibroblast growth factor 23 and the heart.

Detection of exercise-induced pulmonary arterial hypertension by cardiopulmonary exercise testing.

Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension.

Dynamin-mediated Nephrin phosphorylation regulates glucose-stimulated insulin release in pancreatic beta cells.

Regarding Maas's editorial letter on serum suPAR levels.

Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio.

The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.

ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling.

Essential role for synaptopodin in dendritic spine plasticity of the developing hippocampus.

Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.

Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.

Abatacept in B7-1-positive proteinuric kidney disease.

Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

In vivo imaging of kidney glomeruli transplanted into the anterior chamber of the mouse eye.

Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.

Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.

Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.

The prevalence of sleep-disordered breathing among survivors of acute pulmonary embolism.

Hunt for the culprit of cardiovascular injury in kidney disease.

Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.

The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.

The Effect of a Gluten-Free Diet in Children With Difficult-to-Manage Nephrotic Syndrome.

Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

Cardiac actions of fibroblast growth factor 23.

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.